Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| oligodendrocyte precursor cell | 14 studies | 51% ± 19% | |
| glutamatergic neuron | 11 studies | 58% ± 24% | |
| GABAergic neuron | 10 studies | 32% ± 14% | |
| neuron | 7 studies | 32% ± 17% | |
| astrocyte | 5 studies | 66% ± 20% | |
| endothelial cell | 4 studies | 37% ± 19% | |
| Mueller cell | 4 studies | 79% ± 11% | |
| interneuron | 4 studies | 41% ± 28% | |
| microglial cell | 3 studies | 34% ± 18% | |
| glial cell | 3 studies | 39% ± 21% | |
| retinal ganglion cell | 3 studies | 48% ± 20% | |
| Schwann cell | 3 studies | 64% ± 23% | |
| melanocyte | 3 studies | 28% ± 9% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 12 studies | 36% ± 21% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 76% | 1345.33 | 2004 / 2642 | 83% | 5.09 | 584 / 705 |
| skin | 53% | 299.32 | 961 / 1809 | 84% | 14.91 | 395 / 472 |
| thymus | 68% | 427.47 | 446 / 653 | 49% | 3.60 | 299 / 605 |
| prostate | 90% | 785.79 | 221 / 245 | 16% | 0.24 | 80 / 502 |
| bladder | 95% | 1298.10 | 20 / 21 | 5% | 0.10 | 23 / 504 |
| intestine | 95% | 2268.23 | 914 / 966 | 5% | 0.12 | 24 / 527 |
| breast | 54% | 458.40 | 248 / 459 | 39% | 3.52 | 435 / 1118 |
| adrenal gland | 22% | 156.01 | 56 / 258 | 70% | 18.69 | 161 / 230 |
| pancreas | 52% | 202.37 | 169 / 328 | 30% | 0.80 | 53 / 178 |
| esophagus | 75% | 1132.11 | 1082 / 1445 | 4% | 0.13 | 8 / 183 |
| kidney | 58% | 452.11 | 52 / 89 | 12% | 0.65 | 104 / 901 |
| heart | 65% | 477.22 | 558 / 861 | 0% | 0 | 0 / 0 |
| uterus | 52% | 364.77 | 88 / 170 | 10% | 0.48 | 45 / 459 |
| stomach | 53% | 700.41 | 190 / 359 | 7% | 0.21 | 21 / 286 |
| ovary | 24% | 146.12 | 43 / 180 | 26% | 1.27 | 112 / 430 |
| blood vessel | 22% | 195.62 | 299 / 1335 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 20% | 0.51 | 16 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 17% | 0.24 | 5 / 29 |
| adipose | 16% | 111.84 | 197 / 1204 | 0% | 0 | 0 / 0 |
| spleen | 7% | 21.99 | 16 / 241 | 0% | 0 | 0 / 0 |
| liver | 0% | 1.49 | 1 / 226 | 5% | 0.16 | 22 / 406 |
| lung | 0% | 2.61 | 2 / 578 | 4% | 0.13 | 46 / 1155 |
| tonsil | 0% | 0 | 0 / 0 | 2% | 0.04 | 1 / 45 |
| muscle | 1% | 5.41 | 9 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0006892 | Biological process | post-Golgi vesicle-mediated transport |
| GO_0007218 | Biological process | neuropeptide signaling pathway |
| GO_0005794 | Cellular component | Golgi apparatus |
| GO_0016020 | Cellular component | membrane |
| GO_0008188 | Molecular function | neuropeptide receptor activity |
| GO_0005515 | Molecular function | protein binding |
| Gene name | SORCS1 |
| Protein name | SorCS1c-gamma VPS10 domain-containing receptor SorCS1 (hSorCS) SorCS1c-beta Sortilin-related VPS10 domain containing receptor 1, isoform CRA_d (cDNA FLJ78135) Sortilin related VPS10 domain containing receptor 1 |
| Synonyms | SORCS hCG_1811156 |
| Description | |
| Accessions | ENST00000369698.6 E6Y3F9 Q8WY21 E6Y3G0 X6R7D6 H7C2U3 ENST00000452214.5 A8K182 ENST00000263054.11 [Q8WY21-1] |